Intelligent Bio Solutions

Intelligent Bio Solutions Book Value per Share

The Book Value per Share of Intelligent Bio Solutions (INBS) as of Oct 26, 2026 is 3.44 USD. In the previous year, Book Value per Share was 1.87 USD — a change of 83.93% (higher).

Book Value per Share

3.44USD

YoY

83.93%

Last updated:

Book Value per Share of Intelligent Bio Solutions is 2026 3.44 USD. Book Value per Share of Intelligent Bio Solutions was 2025 1.87 USD. It decreases by 83.93% higher compared to the previous year.

The Intelligent Bio Solutions Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2019
-2.88 USD
Jan 1, 2020
-3.24 USD
Jan 1, 2021
9.41 USD
Jan 1, 2022
4.09 USD
Jan 1, 2023
2.37 USD
Jan 1, 2024
5.21 USD
Jan 1, 2025
1.87 USD
Jan 1, 2026
3.44 USD
The Intelligent Bio Solutions Book Value per Share history
YEARBook Value per ShareYoY
3.44USD+83.93%
1.87USD-64.03%
5.21USD+119.25%
2.37USD-41.96%
4.09USD-56.53%
9.41USD-390.33%
-3.24USD+12.38%
-2.88USD+5.48%
-2.73USD-26.00%
-3.70USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligent Bio Solutions Stock analysis

What does Intelligent Bio Solutions do? Intelligent Bio Solutions, Inc. generates revenue through its Commercially available Intelligent Fingerprinting Products (IFPG) segment, which includes a portable drug screening system analyzing fingerprint sweat via a one-time cartridge and handheld reader. The company also develops diagnostic tests under the Development Stage Saliva Glucose Biosensor Platform (SGBP), targeting diabetic patients with a non-invasive saliva glucose biosensor (SGB) intended to replace finger-prick blood monitoring. Its biosensor platform supports multiple biological analyte detection for point-of-care diagnostic tests (POCT) in clinical chemistry, immunology, tumor markers, allergens, and endocrinology. The firm serves primary health practitioners and patients seeking non-invasive monitoring solutions. The company's product portfolio features the IFPG segment's portable drug screening system, which is sold to healthcare providers and law enforcement agencies for rapid drug testing. The SGBP segment focuses on developing the Saliva Glucose Biosensor (SGB), a point-of-care diagnostic test expected to address the needs of diabetic patients requiring frequent glucose monitoring without invasive procedures. The biosensor platform enables detection of multiple analytes, expanding the company's offerings in clinical chemistry and related diagnostic fields. Intelligent Bio Solutions, Inc. targets primary health practitioners and patients as key segments for its non-invasive diagnostic solutions. The IFPG segment's portable drug screening system is designed for use in clinical and law enforcement settings, while the SGBP segment's Saliva Glucose Biosensor aims to provide a convenient alternative to traditional blood glucose monitoring for diabetic patients. The company's development stage products focus on replacing invasive methods with real-time, non-invasive monitoring technologies. Intelligent Bio Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intelligent Bio Solutions stock

Book Value per Share of Intelligent Bio Solutions is 3.44 USD in 2026.

Book Value per Share of Intelligent Bio Solutions changed from 1.87 USD to 3.44 USD, representing a 83.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Intelligent Bio Solutions since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Intelligent Bio Solutions

All Key Metrics — Intelligent Bio Solutions